Published Date: 13 Mar 2023
Maharashtra: Maharashtra University of Health Sciences (MUHS) is an affiliated university...
Read Full News1.
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer
2.
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
3.
Cancerous breast tissue glows in new AI-enhanced MRI images
4.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
5.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
1.
A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era
2.
Beyond the Battle: Navigating Life After Cancer
3.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
4.
Uncovering New Hope for Follicular Lymphoma Patients
5.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation